{
    "nct_id": "NCT05629494",
    "official_title": "Effect of Non-steroidal Anti-inflammatory Drugs on Serum Prostate Specific Antigen Level",
    "inclusion_criteria": "* Male patients age between 18-80 years old with a screening PSA > 3 ng/ml being considered for additional diagnostic testing (e.g., MRI, biopsy)\n* Normal digital rectal examination within the past two years. A documented normal digital rectal examination by another physician or advanced practice provider (NP, PA, etc) is acceptable.\n* No clinical symptoms concerning for acute urinary tract infection (e.g. dysuria, malodorous urine, positive urine culture)\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* History of hypersensitivity or allergy to ibuprofen or NSAIDs.\n* History of peptic ulcer disease, GI bleeding or NSAIDs induced GI adverse events\n* Known bleeding disorders\n* Known severe chronic kidney disease: eGFR < 30 mL/min/1.73 m2\n* Heart failure, significant heart disease\n* Poorly controlled hypertension\n* Active urinary tract infections or bacteriuria\n* Concomitant use of 5-alpha reductase inhibitors (finasteride, dutasteride) unless patient has been taking it for at least 6 months\n* Known prostate cancer or underwent prostate MRI or biopsy in the last year\n* Urinary tract instrumentation in the past 6 weeks (catheter, cystoscopy)\n* Concomitant anti-inflammatory or steroidal drugs\n* Concomitant dual-antiplatelet or anticoagulant therapy use except aspirin 81 mg alone\n* Know history of severe liver disease determined by abnormal liver function tests (elevated AST or ALT > 3X ULN based on exiting history or labs)\n* Any other medical contraindication to NSAIDs",
    "miscellaneous_criteria": ""
}